Navigation Links
Promegas Multiplexed Luciferase Reporter and Cell Viability Assays performed on the PHERAstar

Tracy Worzella and Brad Larson
Promega Corporation, Madison, WI, USA


Application Note 139 Rev. 7/2006

  • Multiplexing homogeneous cell-based assays for analysis of different parameters from a single sample well
  • Monitoring of reporter gene activity and cell viability
  • Assay miniaturization up to 1536-well format

  • Introduction
    Today's high-throughput screening facilities face increasing demands to generate more information from their existing compound libraries. One method of obtaining this information is to run assays sequentially, looking at one parameter followed by another in different plates. While this option may produce the desired data, the increased time and consumable costs are drawbacks. A more appealing method for data generation is to perform assays in a multiplexed format in which several parameters can be measured within the same well. This multiplexed format not only saves time and consumable cost, but also saves on the useage of valuable test compounds.

    This concept of assay multiplexing is demonstrated here using several cell-based assays multiplexed together. There are inherent properties to cell assays that make them attractive for multiplexed cell-based applications. Cell-based assays are especially vulnerable to variations due to differences in cell growth and metabolism that can arise from plate-to-plate. Cell culture itself is also expensive. By multiplexing assays, fewer cells are needed to acquire the same amount of data. Using the same cells for subsequent assays can also ensure more precise data. In this application note, we demonstrate the combination of several Promega cell-based assays multiplexed in both low-volume 384- and 1536-well plate formats. The BMG LABTECH PHERAstar microplate reader is used to record luminescence. Table 1 highlights the assays used in this application.


    Materials and Methods

  • HEK293 cells stably transfected with a CRE/CL1 hPEST Renilla construct
  • Isoproterenol
  • Corning Low-volume 384-well plates, catalog no. 3673
  • Corning 1536-well plates, catalog no. 3937
  • Promega CellTiter-Glo Luminescent Cell Viability Assay, catalog no. G7570*
  • Promega EnduRen Live Cell Substrate, catalog no. E6482*
  • Promega ViviRen Live Cell Substrate, catalog no. E6492*
  • Deerac Fluidics Equator HTS low-volume liquid dispenser
  • BMG LABTECH PHERAstar (figure 1)
  • BMG LABTECH PHERAstar luminescence optic module

  • Multiplexing Luciferase Reporter and Cell Viability Assays
    Promegas luminescent CellTiter-Glo assay was multiplexed with either the luminescent EnduRen Live Cell Substrate, or the luminescent ViviRen Live Cell Substrate. The experimental set-up was similar for each assay combination.

    For the low-volume 384 assay format, a density of 12,000 stably transfected HEK 293 cells per well was plated with the Deerac Fluidics Equator. Cells were allowed to attach for 10 hours at 37C / 10% CO2. EnduRen Live Cell Substrate was added by the Equator to one plate of cells at a final concentration of 60 M and allowed to incubate with the cells for 2 hours at 37C / 10% CO2. 10 M of isoproterenol was added to all test plates to induce CRE. Induction was monitored at 0, 1-, 2-, 3-, and 5-hour time points. At each time point, ViviRen substrate was added by the Equator at a final concentration of 60 M, luminescence reporter signal was recorded, followed by addition of the CellTiter-Glo reagent by the Equator. Luminescence was recorded a second time to measure ATP content and cell number.

    For the 1536-well assay format, a density of 4,000 stably transfected HEK 293 cells per well was plated with the Deerac Fluidics Equator. The remaining multiplex protocols were performed identically to the low-volume 384 protocols listed above.


    Results and Discussion
    To correlate Renilla luciferase reporter gene signal for cell viability, Promegas CellTiter-Glo assay was multiplexed with either the EnduRen Live Cell Substrate or the ViviRen Live Cell Substrate. Both multiplexed assay combinations were prepared in both low-volume 384- and 1536-well format and Renilla expression and cell viability were sequentially measured with BMG LABTECHs PHERAstar in luminsecence mode (figure 2 and figure 3).

    HEK 293 cells were treated with isoproterenol for 5 hours to induce Renilla reporter expression and a correlated kinetic profile of the reporter signal and cell viability were recorded over this time. The EnduRen Live Cell Substrate was added 2 hours before CRE induction and allowed to incubate with the cells. The ViviRen Live Cell Substrate was added directly before each measurement point. After luminescence reporter signal determination, the CellTiter-Glo reagent was added at each measurement point to inactivate Renilla luminescence and initiate ATP-dependent luminescence, which was recorded to measure the cell viability.


    When making correlations between experimental conditions and the expression of a reporter gene, other events associated with cell physiology may affect reporter gene expression. Using live cell reporter substrates, it is possible to track the response of a Renilla reporter in real time by measuring luminescent Renilla reporter activity. Including a cell viability assay allows one to correlate reporter response with overall cell number. For this application, the Renilla reporter expression was optimal at 3 hours of treatment with 10 M isoproterenol in both assay formats tested, regardless of which substrate was used. Cell viability did not change over the time tested, indicating that changes in reporter response were due to the treatment and not changes in cell number. Using the same experimental conditions, the results also show the increased luminescence generated by the ViviRen substrate over the EnduRen substrate. The ViviRen substrate would be a good option when using cell lines that are weakly expressing Renilla luciferase, or for instances when fewer cells are being used as is the case for 1536-well format. Low volume 384 results also correlate with those in 1536, suggesting that miniaturization of these assays does not compromise data quality.


    Conclusion
    Multiplexed cell-based assays allow for multiple parameters to be measured within the same well. With reporter assays, the expression of a luciferase reporter can be greatly affected by the overall health of the cell. By multiplexing a reporter assay with a cell viability assay, it is possible to determine if reporter response variations are due to changes in cell number and health. Depending on the Renilla expression levels or the number of cells being used, the EnduRen and ViviRen Live Cell Substrates provide options for the customer looking to observe real-time reporter kinetics. The sensitivity of the PHERAstar allowed for luminescence detection from both reporter substrates. The data generated here also showcases the ability of BMG LABTECHs PHERAstar to record luminescence from microplates of different well densities up to 1536-wells.


    * See Promegas website for patent marking information
    www.promega.com


    back to top


    '"/>

    Source:


    Page: All 1 2 3 4 5

    Related biology technology :

    1. Promegas Multiplexed Cell Viability and Apoptosis Assays performed on the PHERAstar
    2. Multiplexed Quantitative Peptide Assays for Protein Biomarkers of Cardiovascular Disease in Human Plasma
    3. Stable HeLa Luciferase Reporter Cell Lines Expressing GAL4 Fusion Transactivators
    4. Dual-Luciferase Quantitation in the LMax Microplate Luminometer (MaxLine Application Note #39)
    5. Luciferase Reporter Gene Cells and Recombinant Luciferase Dilutions Studied with the CLIPR Luciferase Assay Kit and the LMax Microplate Luminometer (MaxLine Application Note #38)
    6. New Mammalian Expression Vectors Employ Stable, High-Level Fluorescence Humanized Renilla GFP Reporter
    7. Versatile Reporter Vectors for Monitoring Viral Transduction
    8. New Reporter Plasmids for Studying Interferon-Stimulated Signal Transduction Pathways
    9. Genetic Reporter Systems
    10. Genetic Reporter Systems
    11. Detection of Reporter Gene Activity in Cell Cultures and Murine Epidermis After Helios Gene Gun-Mediated Particle Bombardment
    Post Your Comments:
    (Date:8/27/2014)... 2014 Reportlinker.com announces that a ... its catalogue: Global Biodegradable Packaging ... http://www.reportlinker.com/p02316661/Global-Biodegradable-Packaging-Materials-Market-2014-2018.html About Biodegradable Packaging ... readily decomposed by the action of microorganisms. ... in terms of raw materials, production technology, ...
    (Date:8/27/2014)... Reportlinker.com announces that a new market ... Global Chelating Agents Market 2014-2018 ... Agent A chelating agent is a chemical substance ... thereby forming a metal-ion complex. It reduces the ... processes, formulations, and the environment by chelating with ...
    (Date:8/27/2014)... “We are honored to be named to this ... of Radiant Sage. “We are offering truly ground-breaking clinical ... market to a different level. We are enabling ... and effectively manage the massive amounts of medical imaging ... read by trained physicians. Being recognized by technology industry ...
    (Date:8/27/2014)... , Aug. 27, 2014 Research and ... "Global Enzyme for Pulp & Paper Industry Report 2014" ... Global Enzyme for Pulp & Paper Industry Report 2014 ... state of the global enzyme for pulp & paper ... of the industry including definitions, classifications, applications and industry ...
    Breaking Biology Technology:Global Biodegradable Packaging Materials Market 2014-2018 2Global Biodegradable Packaging Materials Market 2014-2018 3Global Biodegradable Packaging Materials Market 2014-2018 4Global Biodegradable Packaging Materials Market 2014-2018 5Global Biodegradable Packaging Materials Market 2014-2018 6Global Biodegradable Packaging Materials Market 2014-2018 7Global Chelating Agents Market 2014-2018 2Global Chelating Agents Market 2014-2018 3Global Chelating Agents Market 2014-2018 4Radiant Sage Named to CIOReview List of 100 Most Promising Technology Companies 2Global Enzyme for Pulp & Paper Industry Report 2014 2
    ... The Board of,Directors, meeting today under the chairmanship of Albert Saporta, approved,STALLERGENES, half year consolidated financial statements:, (EUR millions) ... ... % ... change, Sales ...
    ... NLTX ), today announced that Peter Strumph, Chief ... the Biotech Industry,conference on Thursday, September 4, at 1:30 ... City. Mr. Strumph will provide a company,overview and update ... The presentation will be webcast live and can be ...
    ... Aug. 27 Poniard,Pharmaceuticals, Inc. (Nasdaq: PARD ... that Jerry McMahon, Ph.D., chairman and CEO,will participate ... he,will provide a corporate overview, including a discussion ... lead product candidate., -- The Thomas Weisel ...
    Cached Biology Technology:Stallergenes: First Half Year 2008: A 19% Increase in Operating Profit and Net Profit 2Stallergenes: First Half Year 2008: A 19% Increase in Operating Profit and Net Profit 3Nile Therapeutics to Present at BioCentury's NewsMakers in the Biotech Industry Conference 2Poniard Pharmaceuticals Announces Upcoming Conference Participation 2
    (Date:8/27/2014)... America,s megafauna mastodons, short-faced bears, giant ground sloths, ... close to 13,000 years ago at the end of ... has long been debated by scientists who, until recently, ... of scientists, including UC Santa Barbara,s James Kennett, professor ... a comet collision with Earth played a major role ...
    (Date:8/27/2014)... About 400 million years ago a group of fish began ... birds, and mammals. But just how these ancient fish used ... what evolutionary processes were at play remain scientific mysteries. ... Nature , turned to a living fish, called Polypterus ... first attempted to walk out of the water. Polypterus ...
    (Date:8/27/2014)... invasive grass species frequently found in forests has created ... on American toads, a new University of Georgia study ... to the U.S. in the early 1900s, is one ... to more than a dozen states in the past ... and in forests, it can survive in widely diverse ...
    Breaking Biology News(10 mins):Nanodiamonds are forever 2Nanodiamonds are forever 3Walking fish reveal how our ancestors evolved onto land 2More wolf spiders feasting on American toads due to invasive grass, UGA study shows 2More wolf spiders feasting on American toads due to invasive grass, UGA study shows 3
    ... in dogs in western and central Africa comes from ... years ago, probably by European colonialists. In the current ... team of scientists from Africa, USA and France report ... at country level and that there is only limited ...
    ... supports a modest beneficial effect of anakinra for rheumatoid ... infections and its use with other biologic medications. ... many as one in 100 people worldwide. It affects ... one of a new breed of arthritis drugs licensed ...
    ... operations necessary to treat stroke victims, confront hardened arteries ... be made safer as researchers from the Micro/Nanophysics Research ... to the design of micro-motors small enough to be ... research paper, published today, Tuesday, 20 January, in IOP ...
    Cached Biology News:Hope for a rabies eradication strategy in Africa 2Anakinra for rheumatoid arthritis: A modest benefit with some risk 2Microbot motors fit to swim human arteries 2
    ... RNaseOUT Recombinant Ribonuclease Inhibitor is ... pancreatic-type ribonucleases such as RNase ... RNaseOUT Recombinant Ribonuclease Inhibitor is ... molecular weight ~52 kDa. RNaseOUT ...
    ... Natural and Recombinant RNasin Ribonuclease Inhibitors ... the inhibition of eukaryotic RNases of the ... its inhibitory effect by noncovalently binding to ... value for the binding of RNasin Ribonuclease ...
    UGT1A7 (E-15)...
    ... Immunogen: synthetic peptide corresponding to the ... dopamine receptor, conjugated to KLH. The ... rat and mouse gene. Physical form: ... containing 0.01% sodium azide. Titertest method: ...
    Biology Products: